INTERNATIONAL PATENT: MORPHIC THERAPEUTIC, INC. FILES APPLICATION FOR "HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN"

GENEVA, May 28 -- MORPHIC THERAPEUTIC, INC. (35 Gatehouse Drive, A2Waltham, Massachusetts 02451) filed a patent application (PCT/US2024/055880) for "HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN" on Nov 14, 2024. With publication no. WO/2025/106644, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BUCKMELTER, Alex (c/o Morphic Therapeutic, Inc.35 Gatehouse Drive, A2Waltham, Massachusetts 02451), CHONG, Katherine (c/o Morphic Therapeutic, Inc.35 Gatehouse Drive, A2Waltham, Massachusetts 02451), DOWLING, Ja...